Package 67457-524-33

Brand: ibandronate sodium

Generic: ibandronate sodium
NDC Package

Package Facts

Identity

Package NDC 67457-524-33
Digits Only 6745752433
Product NDC 67457-524
Product ID 67457-524_270c89b1-757a-41ef-8067-d9034a4bdc9e
Description

1 SYRINGE, GLASS in 1 CARTON (67457-524-33) / 3 mL in 1 SYRINGE, GLASS

Marketing

Marketing Status
Discontinued 2026-05-31
Brand ibandronate sodium
Generic ibandronate sodium
Sample Package No

Linked Drug Pages (1)

ibandronate sodium ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "270c89b1-757a-41ef-8067-d9034a4bdc9e", "openfda": {"unii": ["J12U072QL0"], "rxcui": ["904952"], "spl_set_id": ["a70566e1-cbe5-472a-85ae-08a14117552a"], "manufacturer_name": ["Mylan Institutional LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, GLASS in 1 CARTON (67457-524-33)  / 3 mL in 1 SYRINGE, GLASS", "package_ndc": "67457-524-33", "marketing_end_date": "20260531", "marketing_start_date": "20140902"}], "brand_name": "ibandronate sodium", "product_id": "67457-524_270c89b1-757a-41ef-8067-d9034a4bdc9e", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Bisphosphonate [EPC]", "Diphosphonates [CS]"], "product_ndc": "67457-524", "generic_name": "ibandronate sodium", "labeler_name": "Mylan Institutional LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ibandronate sodium", "active_ingredients": [{"name": "IBANDRONATE SODIUM", "strength": "3 mg/3mL"}], "application_number": "ANDA202671", "marketing_category": "ANDA", "marketing_end_date": "20260531", "marketing_start_date": "20140902"}